UNI-EN 134:The annual meeting with the investors of Sopharma AD and Sopharma Trading AD was held
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 134 | / | 2018 | |||||||
| Date of issue: | 2018-11-20 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| The annual meeting with the investors of Sopharma AD and Sopharma Trading AD was held | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) announces that on November 16, 2018 in Sofia, 16, Rozhen Blvd was held an annual meeting with the investors of Sopharma AD and Sopharma Trading AD, which started at 13:30 and ended at 17:00. 62 guests were registered for the meeting. The meeting started with questions from the investors towards the management of Sopharma AD and Sopharma Trading AD. Mr. Dimitrov presented the largest logistic center of Sopharma Trading AD which is stretched over an area of 15 000 m2 and the storage area is 10 000 m2. In the center is implemented the automated system for warehouse management and medicine distribution – KNAPP, which has no analogue on the Balkan Peninsula. The modern technology accelerates the processing of customer orders 7 times. The guests of the meeting had the opportunity to visit the Regional distribution center of Sopharma Trading AD, automated with the KNAPP system. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 3JR_2018_Investors_meeting_held_espi.pdf 3JR_2018_Investors_meeting_held_espi.pdf | The annual meeting with the investors of Sopharma AD and Sopharma Trading AD was held | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2018-11-20 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 9.1 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
